申请人:SALK INSTITUTE FOR BIOLOGICAL STUDIES
公开号:US20170342088A1
公开(公告)日:2017-11-30
In certain aspects, the invention provides a method for treating a disease or condition in a subject, the method comprising co-administering to a subject in need thereof a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine, and a therapeutically effective amount of an mTOR inhibitor.